The concomitant usage of oxycodone HCl with all cytochrome P450 3A4 inhibitors may cause a rise in oxycodone plasma concentrations, which could maximize or prolong adverse reactions and could result in perhaps fatal respiratory melancholy. Furthermore, discontinuation of the concomitantly used cytochrome P450 3A4 inducer may well lead to a rise in